Malignant Central Nervous System Neoplasm

Malignant Central Nervous System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

2,864 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 822
Recruiting: 449
Ph III recruiting: 27
Growth YoY: +21.1%
Industry share: 16%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.9%
Trials / 1,000 deaths: 45.2 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (419)

clinicaltrialsPublishedShowing 101–125 of 125 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01478854	Neural Progenitor Cell Sparing Radiation Therapy Plus Temozolomide	completed	N/A	33	Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER	1	Jun 13, 2019	clinicaltrials
NCT03075514	Ketogenic Diets as an Adjuvant Therapy in Glioblastoma(KEATING)	completed	N/A	12	University of LiverpoolOTHER	1	Apr 4, 2019	clinicaltrials